Eric Fader was interviewed for the Part B News article, “Attesting to a patient or candidate’s health? Sure, but don’t fudge the truth.”

Click here to read the full article.

On Thursday, May 7, 2020, Benjamin Malerba and Jeff Kaiser will participate in a panel discussion sponsored by the Long Island Chapter of the Association of Certified Fraud Examiners.

The program, to be held at the Westbury Manor, will feature a panel of experts discussing the detection and prosecution of healthcare fraud.

For details and

Eric Fader was quoted in an article, “Court throws out fee policies for medical record sharing; watch for new rules,” in Part B News. The article discussed the recent court decision in Ciox Health, LLC v. Alez Azar, et al., which led to the Department of Health and Human Services modifying its guidance regarding patients’

Marc Ullman will be presenting at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Seminar on April 16-17, 2020 at the Hilton Garden Inn Melville in Plainview, New York.

EAS Consulting Group will be conducting the seminar to help firms prepare for

Marc Ullman was quoted in the Natural Products Insider article, “Sweeping changes proposed to dietary supplement notification system.”

Click here to read the article.

Evan H. Krinick, Managing Partner of Rivkin Radler LLP, is pleased to announce that Michelle A. Bholan,  James R. Finn, Tamika N. Hardy, Steven T. Henesy and Joshua D. Smith have been elected Partners.

“These attorneys are excellent advocates in their respective practice areas who are deeply committed to serving our clients,” Krinick said. “We

Marc Ullman was quoted in the NutraIngredients-USA article, “Across the Nutra-verse: New York’s hemp regulations, Poland’s new vitamin level limits, and more.”

Click here to read the article.

Marc Ullman was quoted in a Nutraingredients-USA article, “New York law sets stage for strictly regulated market for cannabinoids.” New York state recently put into place regulations that govern hemp cultivation within its boarders.

Click here to read the article.

Marc Ullman was quoted in a Natural Products Insider article, “CBD industry hit with nearly half a dozen class action lawsuits.” The FDA’s batch of warning letters last month to CBD marketers spawned a growing number of proposed class action lawsuits.

Click here to read the article.

Eric Fader contributed to Healthcare Risk Management’s HIPAA Regulatory Alert, which appeared in the publication’s December 2019 issue. The Alert outlines the best practices that will help avoid common HIPAA violations. Eric discusses the events that might trigger a regulatory action and the kinds of violations that may affect the severity of the penalties and fines.